Fiffie v. Eagle, Inc. et al, No. 2:2022cv00189 - Document 86 (E.D. La. 2023)
Court Description: ORDER AND REASONS: granting 61 Motion for Summary Judgment, as stated herein. Signed by Judge Barry W Ashe on 03/30/2023. (am)
Download PDF
<![CDATA[
Fiffie v. Eagle, Inc. et al Doc. 86 Case 2:22-cv-00189-BWA-DPC Document 86 Filed 03/30/23 Page 1 of 2 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA ROLAND FIFFIE, SR. CIVIL ACTION VERSUS NO. 22-189 EAGLE, INC., et al. SECTION M (2) ORDER & REASONS Before the Court is a motion for summary judgment filed by defendant Eagle, Inc. (“Eagle”),1 in which defendants Uniroyal Holding, Inc., International Paper Company, Chevron USA, Inc., Anco Insulations, Inc., Berkshire Hathaway Specialty Insurance Company, United States Fidelity and Guaranty Company, Occidental Chemical Corporation, CBS Corporation, Goulds Pumps LLC, and Grinnell LLC join.2 The motion is set for submission on April 6, 2023. Local Rule 7.5 of the United States District Court for the Eastern District of Louisiana requires that a memorandum in opposition to a motion be filed no later than eight days before the noticed submission date, making the deadline in this instance March 29, 2023. Plaintiff Roland Fiffie, Sr., who is proceeding pro se and received service of the motion by United States mail, did not respond in opposition.3 Accordingly, because the motion is unopposed and appears to have merit,4 1 R. Doc. 61. R. Doc. 80. 3 A pro se litigant is not exempt from compliance with established rules of practice and procedure, Birl v. Estelle, 660 F.2d 592, 593 (5th Cir. 1981), and courts “expect litigants to meet court deadlines and observe the rules of civil procedure.” Jones v. FJC Sec. Servs., Inc., 612 F. App’x 201, 203 (5th Cir. 2015). 4 This matter concerns claims of occupational asbestos exposure. On July 7, 2021, Fiffie filed this action in state court alleging that he was exposed to asbestos while working for various employers and that such exposure caused him to develop asbestosis. R. Doc. 1-2 at 1-25. Defendant Huntington Ingalls Inc. (“Avondale”) removed the action to federal court under 28 U.S.C. § 1442(a)(1), the federal officer removal statute. R. Doc. 1 at 1-14. Fiffie was deposed on December 15, 2021. At his deposition, Fiffie admitted that he settled an asbestosis claim he made under the Longshore and Harbor Worker’s Compensation Act (“LHWCA”) against Avondale in 2009, and that he thinks he was first diagnosed with asbestosis prior to 1999. R. Doc. 61-4 at 8-14. Eagle now moves for summary judgment, arguing that Fiffie’s tort claims are prescribed because they were filed more than one year after his LHWCA claim was discharged and no longer pending. R. Doc. 61-3 at 1-8. A federal court sitting in diversity applies state substantive 2 Dockets.Justia.com Case 2:22-cv-00189-BWA-DPC Document 86 Filed 03/30/23 Page 2 of 2 IT IS ORDERED that Eagle’s motion for summary judgment (R. Doc. 61) is GRANTED, and Fiffie’s claims against Eagle, Uniroyal Holding, Inc., International Paper Company, Chevron USA, Inc., Anco Insulations, Inc., Berkshire Hathaway Specialty Insurance Company, United States Fidelity and Guaranty Company, Occidental Chemical Corporation, CBS Corporation, Goulds Pumps LLC, and Grinnell LLC are DISMISSED WITH PREJUDICE. New Orleans, Louisiana, this 30th day of March, 2023. ________________________________ BARRY W. ASHE UNITED STATES DISTRICT JUDGE law, see Erie R.R. Co. v. Tompkins, 304 U.S. 64, 78 (1938), including “state statutes of limitations and related state law governing tolling of the limitation period.” Hensgens v. Deere & Co., 869 F.2d 879, 880 (5th Cir. 1989). Under Louisiana law, liberative prescription is similar to the common-law concept of statute of limitations. It “is a mode of barring of actions as a result of inaction for a period of time.” La. Civ. Code. art. 3447. Louisiana Civil Code article 3492 provides: “Delictual actions are subject to a liberative prescription of one year [that] commences to run from the day injury or damage is sustained.” “Damage is considered to have been sustained, within the meaning of the article, only when it has manifested itself with sufficient certainty to support accrual of a cause of action.” Cole v. Celotex Corp., 620 So. 2d 1154, 1156 (La. 1993). The party pleading prescription usually bears the burden of proof. Younger v. Marshall Indus., Inc., 618 So. 2d 866, 869 (La. 1993). However, if a claim appears to be prescribed on the face of the complaint, the burden shifts to the plaintiff to prove a suspension or interruption of the prescriptive period. Id. Prescription can be interrupted when the obligee files an action in a court of competent jurisdiction and venue, La. Civ. Code art. 3462, and such interruption continues as long as the suit is pending. Id. art. 3463. A claim under the LHWCA acts to interrupt prescription on a tort action. Andrews v. Strauss, 2002 WL 31375610, at *2 (E.D. La. Oct. 18, 2002). Here, Fiffie was first diagnosed with asbestosis in 1999, and he settled his LHWCA claim concerning the asbestosis in 2009. Fiffie’s LHWCA claim interrupted prescription of any claim against a solidary obligor liable in tort for the asbestosis injury, and such interruption continued so long as the claim was pending. But prescription on the tort claims commenced anew once the LHWCA claim was settled, and Fiffie waited more than one year after the LHWCA claim was resolved to file the instant tort action. Thus, Fiffie’s tort claims are prescribed on the face of the complaint, and he has not provided any countervailing evidence to prove a further suspension or interruption of prescription. Accordingly, the claims are properly dismissed. 2
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
